Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Feb 15:14:5.
doi: 10.1186/s12950-017-0152-9. eCollection 2017.

Influence of vaginal lactoferrin administration on amniotic fluid cytokines and its role against inflammatory complications of pregnancy

Martina Maritati  1 , Manola Comar  2 , Nunzia Zanotta  3 , Silva Seraceni  2 , Alessandro Trentini  4 , Fabrizio Corazza  5 , Fortunato Vesce  6 , Carlo Contini  1
Affiliations

Influence of vaginal lactoferrin administration on amniotic fluid cytokines and its role against inflammatory complications of pregnancy

Martina Maritati et al. J Inflamm (Lond). .

Abstract

Background: An altered amniotic cytokine profile has been reported in inflammatory pregnancy complications with a leading role for IL-6, a marker of the foetal systemic inflammatory response. Up to this date there is no exhaustive information neither on the foetal cytokine balance nor on the best method for its modulation. We aimed to evaluate the influence of vaginal lactoferrin administration on amniotic fluid concentration of 47 cytokines, chemokines and growth factors.

Methods: Sixty women undergoing genetic amniocentesis were enrolled in an open-label clinical trial. 300 mg of vaginal lactoferrin (Florence, Italy) were randomly administered to obtain 3 groups: A, 20 untreated patients; B and C (20 patients in each) respectively treated 4 and 12 h before amniocentesis. Cytokines, chemokines and growth factors concentrations were quantified by a magnetic bead Luminex multiplex immunoassays panel technology. Data analysis was performed with the software Stata (v. 13.1) and GraphPad Prism (v. 5). Group comparisons were performed using Kruskal-Wallis followed by Mann-Whitney U tests, with Bonferroni correction for multiple comparisons. A p < 0.05 was considered significant.

Results: Among the 47 tested mediators, 24 (51.06%) were influenced by lactoferrin. 11 (23.4%), showed a highly significant difference (p <0.001); among these IL-9, IL-15, IFN-γ, IP-10, TNF-α, IL-1α and MCP-3 underwent a down-regulation, while IL-17 and FGF-basic, G-CSF, GM-CSF an up-regulation. Difference between group C and both B and A was small for IL-15, IP-10, IL-1α, MCP-3, while it was negligible for IL-9, IFN-γ and TNF-α. IL-17 and the 3 growth factors were strongly enhanced in B and C groups. IL-17, FGF-basic and GM-CSF showed increasing concentrations in both B and C groups, while G-CSF resulted up-regulated only in group C. Significance was intermediate (p < 0.01) for the down regulated IL-2RA, IL-12p40 and IFNα2 (6.38%) while it was small for 10 mediators (21.27%) 7 of which (IL-2, IL-4, eotaxin, PDGF-BB, RANTES, IL-18 and MIF) down-regulated and 3 (MCP-1, IL-3, and SDF-1α) up-regulated.

Conclusion: Lactoferrin down-regulates 17 pro-inflammatory amniotic mediators while up-regulating 7 anti-inflammatory amniotic mediators, 5 of which definitively belonging to an anti-inflammatory profile. These findings open to clinical investigation on its use against inflammatory complications of pregnancy.

Keywords: Abortion; Amniocentesis; Amniotic fluid; Cytokines; Inflammatory complications; Lactoferrin; Mediators; Pregnancy.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Differences among strongly down-regulated mediators in the three groups. Legend: Data are given as medians (quartiles) (pg/ml); ***p < 0.001; **p < 0.01; *p < 0.05
Fig. 2
Fig. 2
Differences among strongly up-regulated mediators in the three groups. Legend: Data are given as medians (quartiles) (pg/ml); ***p < 0.001; **p < 0.01; *p < 0.05
See this image and copyright information in PMC

References

    1. Pazos M, Sperling RS, Moran TM, Kraus TA. The influence of pregnancy on systemic immunity. Immunol Res. 2012;54(1–3):254–61. doi: 10.1007/s12026-012-8303-9. - DOI - PMC - PubMed
    1. Lunghi L, Ferretti ME, Medici S, Biondi C, Vesce F. Control of human trophoblast function. Reprod Biol Endocrinol. 2007;5:6. doi: 10.1186/1477-7827-5-6. - DOI - PMC - PubMed
    1. Vesce F, Scapoli C, Giovannini G, Tralli L, Gotti G, Valerio A, et al. Cytokine imbalance in pregnancies with foetal chromosomal abnormalities. Hum Reprod. 2002;17(3):803–8. doi: 10.1093/humrep/17.3.803. - DOI - PubMed
    1. Vesce F, Scapoli C, Giovannini G, Piffanelli A, Geurts-Moespot A, Sweep FC. Plasminogen activator system in serum and amniotic fluid of euploid and aneuploid pregnancies. Obstet Gynecol. 2001;97(3):404–8. - PubMed
    1. Romero R, Gomez R, Ghezzi F, Yoon BH, Mazor M, Edwin SS, et al. A fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition. Am J Obstet Gynecol. 1998;179(1):186–93. doi: 10.1016/S0002-9378(98)70271-6. - DOI - PubMed

LinkOut - more resources